{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T09:25:14Z","timestamp":1787131514887,"version":"build-2736575974"},"reference-count":166,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Diabetes mellitus (diabetes) is a major health burden with the highest mortality rate, affecting an estimated 537 million adults worldwide. The treatment of diabetes remains complex owing to insulin resistance, \u03b2-cell dysfunction, metabolic inflammation, and progressive organ damage. While G-protein-coupled receptors (GPCRs) selectively suppress many pathological diseases, the functional characteristics of orphan GPCRs (oGPCRs) remain unexplored as therapeutic targets for diabetes. This review comprehensively evaluates oGPCRs and their roles in diabetes. Orphan receptors are classified based on their functional groups: i) insulin secretagogues such as GPR119 and GPR142, ii) transcriptional and regulatory modulators such as GPR27, and iii) metabolic sensors such as GPR75 and GPR91. We further explored the biological roles of these receptors in the pancreas, adipose tissue, liver, and kidneys. In addition, we mapped the convergence of oGPCR signaling with the pharmacological properties of FDA-approved antidiabetic therapies. The major roles of incretin signaling, AMPK-mediated energy sensing, insulin secretion pathways, inflammatory signaling networks, and sodium-glucose cotransporter 2 (SGLT2) -associated organ protection are addressed. We also report the functionality of these receptors on a receptor-by-receptor basis and prioritize them based on biological relevance, druggability, and translational feasibility. Furthermore, potential repurposable drugs targeting oGPCR pathways, along with existing nondiabetic medications, are highlighted. Finally, we discuss how emerging technologies, including single-cell RNA sequencing, spatial transcriptomics, and artificial intelligence- and structure-based drug design, accelerate GPCR deorphanization and therapeutic development. Overall, this report highlights the significant role of oGPCRs as therapeutic targets and drug repurposing opportunities for developing precision medicine and emphasizes the need for further research on oGPCR signaling in the treatment of diabetes.<\/jats:p>","DOI":"10.3389\/fendo.2026.1916297","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:32:23Z","timestamp":1787128343000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Orphan GPCRs in diabetes mellitus: metabolic control, inflammation, and drug development"],"prefix":"10.3389","volume":"17","author":[{"given":"Sureka","family":"Chandrabose","sequence":"first","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, Prince Sattam Bin Abdulaziz University","place":["Al-Kharj, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikraman","family":"Muniyandi","sequence":"additional","affiliation":[{"name":"Molecular Signaling Group, Faculty of Medicine and Health Technology, Tampere University","place":["Tampere, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Geddawy","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, Prince Sattam Bin Abdulaziz University","place":["Al-Kharj, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Thiyagarajan","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, Prince Sattam Bin Abdulaziz University","place":["Al-Kharj, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshaya","family":"Murugesan","sequence":"additional","affiliation":[{"name":"Molecular Signaling Group, Faculty of Medicine and Health Technology, Tampere University","place":["Tampere, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshisundaram","family":"Kandhavelu","sequence":"additional","affiliation":[{"name":"Molecular Signaling Group, Faculty of Medicine and Health Technology, Tampere University","place":["Tampere, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S2213-8587(13)70112-8","article-title":"Diabetes: a 21st century challenge","volume":"2","author":"Zimmet","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S319895","article-title":"A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives","volume":"14","author":"Reed","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30106-6","article-title":"Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer","volume":"1","author":"Hart","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2010.05.008","article-title":"Maturity onset diabetes of the young and pregnancy","volume":"24","author":"Colom","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5114\/pm.2017.68589","article-title":"Diabetes in the elderly","volume":"16","author":"Mordarska","year":"2017","journal-title":"Prz Menopauzalny"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0669","article-title":"Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050","volume":"35","author":"Imperatore","year":"2012","journal-title":"Diabetes Care"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1497298","article-title":"Current views on etiology, diagnosis, epidemiology and gene therapy of maturity onset diabetes in the young","volume":"15","author":"Dzhemileva","year":"2025","journal-title":"Front Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.2004","article-title":"Diabetes mellitus, the fastest growing global public health concern: early detection should be focused","volume":"7","author":"Hossain","year":"2024","journal-title":"Health Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-012-0302-7","article-title":"Metabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms","volume":"12","author":"Intine","year":"2012","journal-title":"Curr Diabetes Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s10020-024-00824-9","article-title":"An update on chronic complications of diabetes mellitus: from molecular mechanisms to therapeutic strategies with a focus on metabolic memory","volume":"30","author":"Yang","year":"2024","journal-title":"Mol Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.3390\/jcm14103364","article-title":"The future diabetes mortality: challenges in meeting the 2030 sustainable development goal of reducing premature mortality from diabetes","volume":"14","author":"Wagh","year":"2025","journal-title":"J Clin Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/193229680800200301","article-title":"Personalized medicine for diabetes","volume":"2","author":"Klonoff","year":"2008","journal-title":"J Diabetes Sci Technol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.51151","article-title":"Novel therapies in diabetes: a comprehensive narrative review of GLP-1 receptor agonists, SGLT2 inhibitors, and beyond","volume":"15","author":"Olanrewaju","year":"2023","journal-title":"Cureus"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.123.001015","article-title":"The role of G protein\u2013coupled receptors and receptor kinases in pancreatic \u03b2-cell function and diabetes","volume":"76","author":"Varney","year":"2024","journal-title":"Pharmacol Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/srep46600","article-title":"A comparative analysis of human and mouse islet G-protein coupled receptor expression","volume":"7","author":"Amisten","year":"2017","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2174\/0115748936264692230921071504","article-title":"Bioinformatics perspective of drug repurposing","volume":"19","author":"Patel","year":"2024","journal-title":"Curr Bioinf"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.08.097","article-title":"Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion","volume":"400","author":"Yoshida","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI61953","article-title":"G protein\u2013coupled receptor 21 deletion improves insulin sensitivity in diet-induced obese mice","volume":"122","author":"Osborn","year":"2012"},{"key":"B20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/joim.12528","article-title":"Targeting orphan G protein coupled receptors for the treatment of diabetes and its complications: C-peptide and GPR146","volume":"281","author":"Kolar","year":"2017","journal-title":"J Intern Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3109\/10799893.2014.926926","article-title":"Expression of orphan receptors GPR22 and GPR162 in streptozotocin-induced diabetic rats","volume":"35","author":"Ruiz-Hern\u00e1ndez","year":"2015","journal-title":"J Recept Signal Transduction"},{"key":"B22","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.1038\/s41598-020-62358-4","article-title":"Deletion of Gpr27 in vivo reduces insulin mRNA but does not result in diabetes","volume":"10","author":"Chopra","year":"2020","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00018-010-0517-1","article-title":"GPR39: a Zn2+-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions","volume":"68","author":"Popovics","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s43556-023-00156-w","article-title":"Structure, function and drug discovery of GPCR signaling","volume":"4","author":"Cheng","year":"2023","journal-title":"Mol BioMed"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2026.2662413","article-title":"Therapeutic targeting of adhesion GPCRs: a status update and future potential","volume":"21","author":"Stillwell","year":"2026","journal-title":"Expert Opin Drug Discov"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010617-052933","article-title":"Adhesion G protein-coupled receptors as drug targets","volume":"58","author":"Purcell","year":"2018","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41392-024-01925-x","article-title":"Adhesion G protein-coupled receptor latrophilin 1 (ADGRL1): a novel regulator of glucose and energy homeostasis","volume":"9","author":"Chhabra","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"B28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1124\/pr.117.014373","article-title":"G protein\u2013coupled receptors targeting insulin resistance, obesity, and type 2 diabetes mellitus","volume":"70","author":"Riddy","year":"2018","journal-title":"Pharmacol Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2019.110592","article-title":"Orphan G-protein coupled receptor 183 (GPR183) potentiates insulin secretion and prevents glucotoxicity-induced \u03b2-cell dysfunction","volume":"499","author":"Taneera","year":"2020","journal-title":"Mol Cell Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/science.1237013","article-title":"GPR15-mediated homing controls immune homeostasis in the large intestine mucosa","volume":"340","author":"Kim","year":"2013","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03083-w","article-title":"Structures of the glucocorticoid-bound adhesion receptor GPR97\u2013Go complex","volume":"589","author":"Ping","year":"2021","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/2211-5463.13516","article-title":"Orphan receptor GPR50 attenuates inflammation and insulin signaling in 3T3\u2010L1 preadipocytes","volume":"13","author":"Yao","year":"2022","journal-title":"FEBS Open Bio"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2021.166288","article-title":"GPR65 (TDAG8) inhibits intestinal inflammation and colitis-associated colorectal cancer development in experimental mouse models","volume":"1868","author":"Marie","year":"2022","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.str.2022.04.006","article-title":"Structures of oxysterol sensor EBI2\/GPR183, a key regulator of the immune response","volume":"30","author":"Chen","year":"2022","journal-title":"Structure"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.1031","article-title":"GPR65 inhibits experimental autoimmune encephalomyelitis through CD4+ T cell independent mechanisms that include effects on iNKT cells","volume":"96","author":"Wirasinha","year":"2018","journal-title":"Immunol Cell Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2337\/db08-1237","article-title":"GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell","volume":"58","author":"Lauffer","year":"2009","journal-title":"Diabetes"},{"key":"B37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/ng.1053","article-title":"Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes","volume":"44","author":"Bonnefond","year":"2012","journal-title":"Nat Genet"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2026.156673","article-title":"GPR84 blockade in macrophages mitigates sepsis-induced liver injury via PPAR\u03b1-driven metabolic reprogramming and M2 polarization","volume":"182","author":"Chen","year":"2026","journal-title":"Metabolism"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1454980","article-title":"Signaling pathways that activate hepatic stellate cells during liver fibrosis","volume":"11","author":"Zhang","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-023-01215-2","article-title":"GPCRs involved in metabolic diseases: pharmacotherapeutic development updates","volume":"45","author":"Jin","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/me.2015-1306","article-title":"GPR119 agonist AS1269574 activates TRPA1 cation channels to stimulate GLP-1 secretion","volume":"30","author":"Chepurny","year":"2016","journal-title":"Mol Endocrinol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1021\/ml400186z","article-title":"Potent and orally bioavailable GPR142 agonists as novel insulin secretagogues for the treatment of type 2 diabetes","volume":"4","author":"Toda","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70576","article-title":"Targeting the LPI\/GPR55 axis in MAFLD and MASH: novel insights, therapeutic strategies and future directions","volume":"46","author":"Lian","year":"2026","journal-title":"Liver Int"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2218\/gtopdb\/F16\/2025.4","article-title":"Class A orphans in GtoPdb v.2025.4","volume":"2025","author":"Alexander","year":"2025","journal-title":"IUPHAR\/BPS Guide to Pharmacol CITE"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108416","article-title":"GPR162 is a beta cell CART receptor","volume":"26","author":"Lindqvist","year":"2023","journal-title":"iScience"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127208","article-title":"Is GPR146 really the receptor for proinsulin C-peptide","volume":"30","author":"Lindfors","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2024.0381","article-title":"The role of FNDC4 in inflammation and metabolism for various diseases","volume":"16","author":"Hu","year":"2024","journal-title":"Aging Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/jnc.12955","article-title":"Understanding CELSRs - cadherin EGF LAG seven-pass G-type receptors","volume":"131","author":"Wang","year":"2014","journal-title":"J Neurochem"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00027.2021","article-title":"Adhesion G protein-coupled receptors: structure, signaling, physiology, and pathophysiology","volume":"102","author":"Lala","year":"2022","journal-title":"Physiol Rev"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012133","article-title":"Functions of the zinc-sensing receptor GPR39 in regulating intestinal health in animals","volume":"23","author":"Xia","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2021.04.012","article-title":"The role of GPR56\/ADGRG1 in health and disease","volume":"44","author":"Singh","year":"2021","journal-title":"Biomed J"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01607","article-title":"Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes","volume":"10","author":"Zatterale","year":"2020","journal-title":"Front Physiol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.05.008","article-title":"Immunological goings-on in visceral adipose tissue","volume":"17","author":"Mathis","year":"2013","journal-title":"Cell Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M101521200","article-title":"Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action","volume":"277","author":"Aguirre","year":"2002","journal-title":"J Biol Chem"},{"key":"B55","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41467-023-35882-w","article-title":"Cryo-EM structures of orphan GPR21 signaling complexes","volume":"14","author":"Lin","year":"2023","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.165469","article-title":"Medium-chain fatty acids suppress lipotoxicity-induced hepatic fibrosis via the immunomodulating receptor GPR84","volume":"8","author":"Ohue-Kitano","year":"2023","journal-title":"JCI Insight"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01419","article-title":"Activation of the immune-metabolic receptor GPR84 enhances inflammation and phagocytosis in macrophages","volume":"9","author":"Recio","year":"2018","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01378","article-title":"Modulation of the G-protein-coupled receptor 84 (GPR84) by agonists and antagonists","volume":"63","author":"Chen","year":"2020","journal-title":"J Med Chem"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.03.169","article-title":"GPR35 is a novel lysophosphatidic acid receptor","volume":"395","author":"Oka","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/sleepadvances\/zpaf030","article-title":"An integrative approach prioritizes the orphan GPR61 genomic region in tissue-specific regulation of chronotype","volume":"6","author":"Tchio","year":"2025","journal-title":"SLEEP Adv"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.21955","article-title":"The N-terminal domain of GPR61, an orphan G-protein-coupled receptor, is essential for its constitutive activity","volume":"87","author":"Toyooka","year":"2009","journal-title":"J Neurosci Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2011.09.002","article-title":"Characterization of metabolic phenotypes of mice lacking GPR61, an orphan G-protein coupled receptor","volume":"89","author":"Nambu","year":"2011","journal-title":"Life Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.molpha.2025.100026","article-title":"Identification and molecular characterization of missense mutations in orphan G protein\u2013coupled receptor GPR61 occurring in severe obesity","volume":"107","author":"Tsang","year":"2025","journal-title":"Mol Pharmacol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1312938110","article-title":"GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feeding","volume":"110","author":"Gomes","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-023-06010-6","article-title":"ADGRL1 is a glucose receptor involved in mediating energy and glucose homeostasis","volume":"67","author":"Chhabra","year":"2024","journal-title":"Diabetologia"},{"key":"B66","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.pharmthera.2014.09.007","article-title":"An atlas of G-protein coupled receptor expression and function in human subcutaneous adipose tissue","volume":"146","author":"Amisten","year":"2015","journal-title":"Pharmacol Ther"},{"key":"B67","doi-asserted-by":"publisher","first-page":"386","DOI":"10.18632\/aging.101743","article-title":"Loss of GPR109A\/HCAR2 induces aging-associated hepatic steatosis","volume":"11","author":"Jadeja","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1038\/s41467-021-22579-1","article-title":"Orphan GPR116 mediates the insulin sensitizing effects of the hepatokine FNDC4 in adipose tissue","volume":"12","author":"Georgiadi","year":"2021","journal-title":"Nat Commun"},{"key":"B69","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/diabetology7040068","article-title":"G protein-coupled receptors in pancreatic \u03b2-cells: From trafficking and localization to insulin secretion and diabetes","volume":"7","author":"Tecucianu","year":"2026","journal-title":"Diabetology"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1021\/jm800258p","article-title":"3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice","volume":"51","author":"Semple","year":"2008","journal-title":"J Med Chem"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf8683","article-title":"Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity","volume":"373","author":"Akbari","year":"2021","journal-title":"Science"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2020.106485","article-title":"20-HETE interferes with insulin signaling and contributes to obesity-driven insulin resistance","volume":"152","author":"Gilani","year":"2021","journal-title":"Prostaglandins Other Lipid Mediators"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15525","article-title":"Uncovering the signalling, structure and function of the 20-HETE-GPR75 pairing: Identifying the chemokine CCL5 as a negative regulator of GPR75","volume":"178","author":"Pascale","year":"2021","journal-title":"Br J Pharmacol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2012.00022","article-title":"The succinate receptor as a novel therapeutic target for oxidative and metabolic stress-related conditions","volume":"3","author":"Ariza","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-025-10670-7","article-title":"From mechanisms to diseases: The succinate-GPR91 axis in cardiometabolic diseases","volume":"18","author":"Jia","year":"2025","journal-title":"J Cardiovasc Transl Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.02.012","article-title":"Adhesion G-protein coupled receptors: Implications for metabolic function","volume":"198","author":"Olaniru","year":"2019","journal-title":"Pharmacol Ther"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1884","article-title":"Adhesion G protein-coupled receptor G1 (ADGRG1\/GPR56) and pancreatic \u03b2-cell function","volume":"101","author":"Dun\u00e9r","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B78","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.gendis.2023.02.016","article-title":"Structure, ligands, and roles of GPR126\/ADGRG6 in the development and diseases","volume":"11","author":"Li","year":"2023","journal-title":"Genes Dis"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.85131","article-title":"Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (Adgrf1)","volume":"12","author":"Wu","year":"2023","journal-title":"eLife"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01810-7","article-title":"Dysfunction of the adhesion G protein-coupled receptor latrophilin 1 (ADGRL1\/LPHN1) increases the risk of obesity","volume":"9","author":"Dietzsch","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154452","article-title":"GPR142 agonists stimulate glucose-dependent insulin secretion via Gq-dependent signaling","volume":"11","author":"Wang","year":"2016","journal-title":"PloS One"},{"key":"B82","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/d41573-020-00029-9","article-title":"GPR84: An immune response dial","volume":"19","author":"Wojciechowicz","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175713","article-title":"GPR160 is not a receptor of anorexigenic cocaine- and amphetamine-regulated transcript peptide","volume":"949","author":"Freitas-Lima","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1126\/science.add7150","article-title":"Orphan receptor GPR158 serves as a metabotropic glycine receptor: mGlyR","volume":"379","author":"Laboute","year":"2023","journal-title":"Science"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3003126","article-title":"Structures of G-protein coupled receptor HCAR1 in complex with Gi1 protein reveal the mechanistic basis for ligand recognition and agonist selectivity","volume":"23","author":"Pan","year":"2025","journal-title":"PloS Biol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2337\/dbi22-0030","article-title":"KATP channels and the metabolic regulation of insulin secretion in health and disease: The 2022 Banting Medal for Scientific Achievement Award Lecture","volume":"72","author":"Ashcroft","year":"2023","journal-title":"Diabetes"},{"key":"B87","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: Mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/pds.70277","article-title":"Dipeptidyl peptidase 4 inhibitors: Novel therapeutic agents in the management of type II diabetes mellitus","volume":"34","author":"Aloke","year":"2025","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.04.055","article-title":"The PPAR\u03b3 agonist pioglitazone represses inflammation in a PPAR\u03b1-dependent manner in vitro and in vivo in mice","volume":"52","author":"Orasanu","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000632","article-title":"Tubular effects of sodium\u2013glucose cotransporter 2 inhibitors: Intended and unintended consequences","volume":"29","author":"Dominguez Rieg","year":"2020","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00400.2012","article-title":"Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice","volume":"304","author":"Potthoff","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13261","article-title":"Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia","volume":"14","author":"Durcan","year":"2022","journal-title":"J Diabetes"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20250120","article-title":"Recent developments in GPCR signalling in appetite regulation","volume":"46","author":"Brittain","year":"2026","journal-title":"Biosci Rep"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.03.008","article-title":"GPCR-mediated signaling of metabolites","volume":"25","author":"Husted","year":"2017","journal-title":"Cell Metab"},{"key":"B96","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrneph.2013.251","article-title":"The effect of RAAS blockade on the progression of diabetic nephropathy","volume":"10","author":"Roscioni","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0659-1","article-title":"The effect of PPAR\u03b3 agonist on SGLT2 and glucagon expressions in alpha cells under hyperglycemia","volume":"40","author":"Kim","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13395","article-title":"A randomized controlled pilot trial of anakinra and pioglitazone for protein metabolism in patients on maintenance haemodialysis","volume":"15","author":"Ertuglu","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212262","article-title":"Empagliflozin: A new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes","volume":"3","author":"Neumiller","year":"2014","journal-title":"Drugs Context"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8917578","article-title":"Update on RAAS modulation for the treatment of diabetic cardiovascular disease","volume":"2016","author":"Bernardi","year":"2016","journal-title":"J Diabetes Res"},{"key":"B101","unstructured":"Oral hypoglycemic medications\n          \n          \n            \n              Ganesan\n              K\n            \n            \n              Rana\n              MBM\n            \n            \n              Sultan\n              S\n            \n          \n          Treasure Island (FL\n          StatPearls Publishing\n          Statpearls\n          \n          2026"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12495","article-title":"Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24-week randomized, double-blind study","volume":"31","author":"Bajaj","year":"2014","journal-title":"Diabetes Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.18549\/PharmPract.2019.4.1588","article-title":"Combination therapy with once-weekly glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a case series","volume":"17","author":"Lajthia","year":"2019","journal-title":"Pharm Pract (Granada)"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-025-01722-x","article-title":"Combining GLP-1 receptor agonists and SGLT2 inhibitors in type 2 diabetes mellitus: a scoping review and expert insights for clinical practice utilizing the nominal group technique","volume":"16","author":"Yepes-Cort\u00e9s","year":"2025","journal-title":"Diabetes Ther"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2024.07.017","article-title":"The direct targets of metformin in diabetes and beyond","volume":"36","author":"Yao","year":"2025","journal-title":"Trends Endocrinol Metab"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000001642","article-title":"Bromocriptine: does this drug of Parkinson\u2019s disease have a role in managing cardiovascular diseases","volume":"86","author":"Kutikuppala","year":"2023","journal-title":"Ann Med Surg (Lond)"},{"key":"B107","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2147\/CE.S26725","article-title":"Colesevelam hydrochloride: evidence for its use in the treatment of hypercholesterolemia and type 2 diabetes mellitus with insights into mechanism of action","volume":"7","author":"Zema","year":"2012","journal-title":"Core Evid"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.70082","article-title":"The role of hydroxychloroquine in the management of rheumatic disorders: a comprehensive review","volume":"137","author":"Ates","year":"2025","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1322148","article-title":"Verapamil chronicles: advances from cardiovascular to pancreatic \u03b2-cell protection","volume":"14","author":"Arefanian","year":"2023","journal-title":"Front Pharmacol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2016.04.075","article-title":"PDE5A polymorphisms influence on sildenafil treatment success","volume":"13","author":"Marchal-Escalona","year":"2016","journal-title":"J Sexual Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13098-022-00825-w","article-title":"Effect of low-dose tadalafil once daily on glycemic control in patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, placebo-controlled pilot study","volume":"14","author":"Lee","year":"2022","journal-title":"Diabetol Metab Syndr"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1177\/15593258221123677","article-title":"Allopurinol use and the risk of type 2 diabetes mellitus: a meta-analysis of cohort studies","volume":"20","author":"Lai","year":"2022","journal-title":"Dose-Response"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-159-1-201307020-00003","article-title":"Salicylate (salsalate) in patients with type 2 diabetes","volume":"159","author":"Goldfine","year":"2013","journal-title":"Ann Intern Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.95715","article-title":"Low-dose csssignalingatients with type 2 diabetes with recent myocardial infarction in the colchicine cardiovascular outcome trial (COLCOT): a systematic review","volume":"17","author":"Shoaib","year":"2024","journal-title":"Cureus"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2601-7","article-title":"Anakinra treatment in patients with gout and type 2 diabetes","volume":"34","author":"Vitale","year":"2015","journal-title":"Clin Rheumatol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101649","article-title":"Canakinumab in patients with COVID-19 and type 2 diabetes \u2013 a multicentre, randomised, double-blind, placebo-controlled trial","volume":"53","author":"Hepprich","year":"2022","journal-title":"eClinicalMedicine"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13706","article-title":"Development of type\u20091 diabetes in a patient treated with anti\u2010interleukin\u20106 receptor antibody for rheumatoid arthritis","volume":"13","author":"Kawasaki","year":"2022","journal-title":"J Diabetes Investig"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.4158\/EP.17.2.306","article-title":"Etanercept-induced hypoglycemia and improved glycemic control in a patient with type 2 diabetes","volume":"17","author":"Farrokhi","year":"2011","journal-title":"Endocrine Pract"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.12.014","article-title":"Infliximab and insulin resistance","volume":"9","author":"Ursini","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B120","doi-asserted-by":"publisher","first-page":"51","DOI":"10.21315\/mjms2018.25.4.5","article-title":"Effects of adalimumab, an anti-tumour necrosis factor-alpha (TNF-\u03b1) antibody, on obese diabetic rats","volume":"25","author":"Shuwa","year":"2018","journal-title":"Malays J Med Sci"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.aace.2024.04.002","article-title":"Rituximab therapy for insulin allergy in type-1 diabetes mellitus","volume":"10","author":"DeClue","year":"2024","journal-title":"AACE Clin Case Rep"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-2200","article-title":"Abatacept for delay of type 1 diabetes progression in stage 1 relatives at risk: a randomized, double-masked, controlled trial","volume":"46","author":"Russell","year":"2023","journal-title":"Diabetes Care"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.2337\/cd23-0033","article-title":"Teplizumab: the first treatment to delay the progression of type 1 diabetes","volume":"41","author":"Goldman","year":"2023","journal-title":"Clin Diabetes"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0080","article-title":"Imatinib mesylate reduces endoplasmic reticulum stress and induces remission of diabetes in db\/db mice","volume":"58","author":"Han","year":"2009","journal-title":"Diabetes"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.2185\/jrm.5.165","article-title":"Open-label, randomized crossover study between telmisartan and valsartan on improving insulin resistance and adipocytokines in nondiabetic patients with mild hypertension","volume":"5","author":"Ohbayashi","year":"2010","journal-title":"J Rural Med"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.5339\/gcsp.2013.34","article-title":"RAAS inhibition and mortality in hypertension","volume":"2013","author":"Ferrari","year":"2013","journal-title":"Glob Cardiol Sci Pract"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-11-1","article-title":"Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study","volume":"11","author":"Zidek","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2025.07.014","article-title":"Beyond lipids: fenofibrate in diabetic retinopathy and nephropathy","volume":"47","author":"Liu","year":"2026","journal-title":"Trends Pharmacol Sci"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-11-140","article-title":"Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention","volume":"11","author":"Tenenbaum","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.65.2.135","article-title":"An evaluation of \u03bc-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence","volume":"65","author":"Anton","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1152\/function.011.2026","article-title":"Melatonin receptor signaling in human pathologies: from molecular mechanisms to therapeutic targets","volume":"7","author":"Huang","year":"2026","journal-title":"Function"},{"key":"B132","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cellsig.2017.04.001","article-title":"Niclosamide: beyond an antihelminthic drug","volume":"41","author":"Chen","year":"2018","journal-title":"Cell Signal"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.prmcm.2025.100689","article-title":"Targeting AMPK signaling: the therapeutic potential of berberine in diabetes and its complications","volume":"17","author":"Mbara","year":"2025","journal-title":"Pharmacol Res Mod Chin Med"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315105","article-title":"Resveratrol-like compounds as SIRT1 activators","volume":"23","author":"Ciccone","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.53366\/jimki.v12i2.1050","article-title":"Pharmacogenomic regulation of the NF-kB\u2013Nrf2 axis by curcumin: a precision molecular approach to inflammation and oxidative stress","volume":"12","author":"Alisya","year":"2026","journal-title":"JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.310525","article-title":"20-HETE signals through G-protein-coupled receptor GPR75 (Gq) to affect vascular function and trigger hypertension","volume":"120","author":"Garcia","year":"2017","journal-title":"Circ Res"},{"key":"B137","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14274","article-title":"Statins and glycaemic control in type 2 diabetes: are bile acids relevant","volume":"86","author":"Sansome","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071736","article-title":"Orphan GPR26 counteracts early phases of hyperglycemia-mediated monocyte activation and is suppressed in diabetic patients","volume":"10","author":"Kichi","year":"2022","journal-title":"Biomedicines"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16325","article-title":"The dark sides of the GPCR tree - research progress on understudied GPCRs","volume":"182","author":"Scharf","year":"2025","journal-title":"Br J Pharmacol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/15.11.2302","article-title":"Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome","volume":"15","author":"de Leo","year":"2000","journal-title":"Hum Reprod"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1994.2480","article-title":"Role of phosphatidylinositol-3-kinase in insulin receptor signaling: studies with inhibitor, LY294002","volume":"204","author":"Sanchez-Marg\u00e1let","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1159\/000473735","article-title":"Selective alpha 1-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experience","volume":"29","author":"Chapple","year":"1996","journal-title":"Eur Urol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.metabol.2017.03.006","article-title":"Treatment with high dose salicylates improves cardiometabolic parameters: meta-analysis of randomized controlled trials","volume":"71","author":"Baye","year":"2017","journal-title":"Metabolism"},{"key":"B145","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s13410-023-01173-9","article-title":"Effect of hydroxychloroquine on beta cell function, insulin resistance, and inflammatory markers in type 2 diabetes patients uncontrolled on glimepiride and metformin therapy","volume":"43","author":"Rajput","year":"2023","journal-title":"Int J Diabetes Dev Ctries"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031034","article-title":"GPR119 and GPR55 as receptors for fatty acid ethanolamides, oleoylethanolamide and palmitoylethanolamide","volume":"22","author":"Im","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0711278105","article-title":"GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current","volume":"105","author":"Lauckner","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3390\/ph17060757","article-title":"Quercetin and kaempferol as multi-targeting antidiabetic agents against mouse model of chemically induced type 2 diabetes","volume":"17","author":"Ali","year":"2024","journal-title":"Pharm (Basel)"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1022053","article-title":"Protective effects and mechanism of puerarin targeting PI3K\/Akt signal pathway on neurological diseases","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.20517\/mrr.2025.33","article-title":"Effect of a polyphenol-rich dietary pattern on subjects aged \u2265 60 years with higher levels of inflammatory markers: insights into microbiome and metabolome","volume":"4","author":"Gargari","year":"2025","journal-title":"mrr"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2016.11.007","article-title":"Hydroxy-carboxylic acid receptor actions in metabolism","volume":"28","author":"Offermanns","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c01905","article-title":"Discovery of a highly potent oxysterol receptor GPR183 antagonist bearing the benzo[d]thiazole structural motif for the treatment of inflammatory bowel disease (IBD)","volume":"67","author":"Zeng","year":"2024","journal-title":"J Med Chem"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910784","article-title":"GPR21 inhibition increases glucose-uptake in HepG2 cells","volume":"22","author":"Kinsella","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.29219\/fnr.v66.7652","article-title":"Citrus maxima and tea regulate AMPK signaling pathway to retard the progress of nonalcoholic fatty liver disease","volume":"66","author":"Wen","year":"2022","journal-title":"Food Nutr Res"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00628","article-title":"Advances in neurobiology and pharmacology of GPR12","volume":"11","author":"Allende","year":"2020","journal-title":"Front Pharmacol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s40200-025-01563-2","article-title":"The PI3K\/Akt pathway: a target for curcumin\u2019s therapeutic effects","volume":"24","author":"Aliyari","year":"2025","journal-title":"J Diabetes Metab Disord"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094084","article-title":"GPR75: Advances, challenges in deorphanization, and potential as a novel drug target for disease treatment","volume":"26","author":"Han","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2017.05.014","article-title":"Succinate, increased in metabolic syndrome, activates GPR91 receptor signaling in urothelial cells","volume":"37","author":"Mossa","year":"2017","journal-title":"Cell Signal"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1254446","article-title":"GPR35 acts a dual role and therapeutic target in inflammation","volume":"14","author":"Wu","year":"2023","journal-title":"Front Immunol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15811","article-title":"Community guidelines for GPCR ligand bias: IUPHAR review 32","volume":"179","author":"Kolb","year":"2022","journal-title":"Br J Pharmacol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01434.x","article-title":"GPCR expression in tissues and cells: Are the optimal receptors being used as drug targets","volume":"165","author":"Insel","year":"2012","journal-title":"Br J Pharmacol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2020.09.012","article-title":"Engineered tissues and strategies to overcome challenges in drug development","volume":"158","author":"Khalil","year":"2020","journal-title":"Adv Drug Delivery Rev"},{"key":"B163","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.cmet.2016.08.020","article-title":"Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes","volume":"24","author":"Segerstolpe","year":"2016","journal-title":"Cell Metab"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1021\/ci500747n","article-title":"Deep neural nets as a method for quantitative structure\u2013activity relationships","volume":"55","author":"Ma","year":"2015","journal-title":"J Chem Inf Model"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.eswa.2023.119648","article-title":"Risk assessment of cardiovascular disease based on SOLSSA-CatBoost model","volume":"219","author":"Wei","year":"2023","journal-title":"Expert Syst Appl"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1342179","article-title":"Cryo-electron microscopy-based drug design","volume":"11","author":"Cebi","year":"2024","journal-title":"Front Mol Biosci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1916297\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:32:26Z","timestamp":1787128346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1916297\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":166,"alternative-id":["10.3389\/fendo.2026.1916297"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1916297","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"article-number":"1916297"}}